NCL, nucleolin, 4691

N. diseases: 167; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1843013
Disease: Alzheimer disease, familial, type 3
Alzheimer disease, familial, type 3
0.010 Biomarker disease BEFREE In addition, nucleolar chromatin regulatory proteins, nucleophosmin 1 (NPM1), upstream binding factor, and nucleolin accumulated in the ViPR body in late-stage Ad infection. 31365788 2020
CUI: C0006413
Disease: Burkitt Lymphoma
Burkitt Lymphoma
0.010 Biomarker disease BEFREE This study aims to explore the effect of NCL on drug sensitivity and its potential mechanism in CA46 Burkitt's lymphoma (BL) cells. 31127617 2019
CUI: C0010054
Disease: Coronary Arteriosclerosis
Coronary Arteriosclerosis
0.010 Biomarker disease BEFREE These findings provide translational relevance of the AMPK-NCL-miR-93/miR-484 axis in miRNA processing in EC health and coronary artery disease. 31182601 2019
CUI: C0010068
Disease: Coronary heart disease
Coronary heart disease
0.010 Biomarker disease BEFREE These findings provide translational relevance of the AMPK-NCL-miR-93/miR-484 axis in miRNA processing in EC health and coronary artery disease. 31182601 2019
CUI: C0014145
Disease: Yolk Sac Tumor
Yolk Sac Tumor
0.010 AlteredExpression disease BEFREE Embryonal carcinomas and yolk sac tumors showed lower expression of NCL than seminomas indicated by H-score. 31513277 2019
CUI: C0036631
Disease: Seminoma
Seminoma
0.010 AlteredExpression disease BEFREE Embryonal carcinomas and yolk sac tumors showed lower expression of NCL than seminomas indicated by H-score. 31513277 2019
CUI: C0039590
Disease: Testicular Neoplasms
Testicular Neoplasms
0.010 AlteredExpression group BEFREE Nucleolin and nucleophosmin expression in seminomas and non-seminomatous testicular tumors. 31513277 2019
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.010 AlteredExpression group BEFREE Effect of nucleolin on adriamycin resistance via the regulation of B-cell lymphoma 2 expression in Burkitt's lymphoma cells. 31127617 2019
CUI: C0206659
Disease: Embryonal Carcinoma
Embryonal Carcinoma
0.010 AlteredExpression disease BEFREE Embryonal carcinomas and yolk sac tumors showed lower expression of NCL than seminomas indicated by H-score. 31513277 2019
CUI: C0278764
Disease: Adult Burkitt Lymphoma
Adult Burkitt Lymphoma
0.010 Biomarker disease BEFREE This study aims to explore the effect of NCL on drug sensitivity and its potential mechanism in CA46 Burkitt's lymphoma (BL) cells. 31127617 2019
CUI: C0278879
Disease: Childhood Burkitt Lymphoma
Childhood Burkitt Lymphoma
0.010 Biomarker disease BEFREE This study aims to explore the effect of NCL on drug sensitivity and its potential mechanism in CA46 Burkitt's lymphoma (BL) cells. 31127617 2019
CUI: C0751072
Disease: Frontotemporal Lobar Degeneration
Frontotemporal Lobar Degeneration
0.010 Biomarker disease BEFREE Considering the growing evidence for altered autophagy in the pathogenesis of neurodegenerative disorders, our findings support a role of NCL genes in FTLD risk and suggest that MFSD8-associated lysosomal dysfunction may contribute to FTLD pathology. 30382371 2019
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.010 Biomarker disease BEFREE These findings provide translational relevance of the AMPK-NCL-miR-93/miR-484 axis in miRNA processing in EC health and coronary artery disease. 31182601 2019
CUI: C1959635
Disease: Parvovirus B19 (disease)
Parvovirus B19 (disease)
0.010 Biomarker disease BEFREE Immunohistochemistry used monoclonal anti-CMV antibody (NCL-CMVpp65, Leica Biosystems, Wetzlar, Germany), anti-PVB19 antibody (NCL-PARVO, Leica Biosystems, Wetzlar, Germany), and anti-HSV1/HSV2 antibodies (NCL-HSV-1 and HSV2, Leica Biosystems, Wetzlar, Germany). 29113531 2019
CUI: C0007102
Disease: Malignant tumor of colon
Malignant tumor of colon
0.010 Biomarker disease BEFREE Nucleolin facilitates nuclear retention of an ultraconserved region containing <i>TRA2β4</i> and accelerates colon cancer cell growth. 29928487 2018
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.010 Biomarker group BEFREE Conclusions- These results demonstrate novel mechanisms involving upregulation of long noncoding RNA Dnm3os, disruption of its interaction with nucleolin, and epigenetic modifications at target genes that promote macrophage inflammatory phenotype in diabetes mellitus. 29930005 2018
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.010 Biomarker disease BEFREE Our study provides evidence that CYP4B1-PS1-001 regulates the ubiquitination and degradation of NCL and thereby plays a critical role in the proliferation and fibrosis of MMCs, indicating that CYP4B1-PS1-001 and NCL may be promising prognostic biomarkers and molecular targets for the treatment of diabetic nephropathy. 30257240 2018
CUI: C0019087
Disease: Hemorrhagic Disorders
Hemorrhagic Disorders
0.010 Biomarker group BEFREE Nucleolin mediates the internalization of rabbit hemorrhagic disease virus through clathrin-dependent endocytosis. 30339712 2018
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
0.010 Biomarker disease BEFREE Pre-B acute lymphoblastic leukemia expresses cell surface nucleolin as a 9-O-acetylated sialoglycoprotein. 30464179 2018
CUI: C0035372
Disease: Rett Syndrome
Rett Syndrome
0.010 AlteredExpression disease BEFREE We confirmed by Western blot analysis that nucleolin protein levels are altered in RTT brain, but not in <i>Mecp2</i>-deficient mice. 30619462 2018
CUI: C0079744
Disease: Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
0.010 Biomarker disease BEFREE Moreover, combining nucleolin inhibitors: aptamer AS1411 or nucant N6L with doxorubicin reduced DLBCL cell survival. 28690315 2018
Secondary malignant neoplasm of lung
0.010 Biomarker disease BEFREE XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIβ mRNA stability. 29250796 2018
CUI: C0235946
Disease: Cerebral atrophy
Cerebral atrophy
0.010 Biomarker disease BEFREE Computed tomography scanning and reconstruction verify that brain atrophy ovine CLN5 NCL originates in the occipital lobes with subsequent propagation throughout the whole cortex and these regional differences are reflected in the ICV loss. 30136763 2018
CUI: C0338106
Disease: Adenocarcinoma of colon
Adenocarcinoma of colon
0.010 Biomarker disease BEFREE Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma. 30007600 2018
CUI: C0858252
Disease: Breast adenocarcinoma
Breast adenocarcinoma
0.010 AlteredExpression disease BEFREE G4 aptamers designed against STAT3, nucleolin and SP1 inhibit STAT3 transcriptional activity in human breast adenocarcinoma MCF-7 cells, and all the studied aptamers inhibit TOP1-mediated relaxation of supercoiled plasmid DNA. 29208488 2018